Upstream Bio (UPB) EBIT Margin (2023 - 2025)
Historic EBIT Margin for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to 5539.39%.
- Upstream Bio's EBIT Margin fell 24268600.0% to 5539.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 5020.08%, marking a year-over-year decrease of 20397400.0%. This contributed to the annual value of 3281.18% for FY2024, which is 15957200.0% down from last year.
- Latest data reveals that Upstream Bio reported EBIT Margin of 5539.39% as of Q3 2025, which was down 24268600.0% from 4732.87% recorded in Q2 2025.
- Over the past 5 years, Upstream Bio's EBIT Margin peaked at 1511.43% during Q3 2023, and registered a low of 5656.01% during Q1 2025.
- For the 3-year period, Upstream Bio's EBIT Margin averaged around 3757.22%, with its median value being 3439.22% (2024).
- Its EBIT Margin has fluctuated over the past 5 years, first crashed by -11088700bps in 2024, then tumbled by -33102300bps in 2025.
- Quarter analysis of 3 years shows Upstream Bio's EBIT Margin stood at 3184.44% in 2023, then crashed by -35bps to 4293.31% in 2024, then decreased by -29bps to 5539.39% in 2025.
- Its last three reported values are 5539.39% in Q3 2025, 4732.87% for Q2 2025, and 5656.01% during Q1 2025.